Information with regards to Melanoma
Dear Nottinghamshire Healthcare NHS Trust,
I would like to please request the following information:
The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.
Q1. In the past 3 months (or the latest 3 months data you have available), how many melanoma patients were treated with:
• Bevacizumab (Avastin)
• Dacarbazine (DTIC)
• Trametinib (Mekinist)
• Dabrafenib (Tafinlar)
• Ipilimumab (Yervoy)
• Vemurafenib (Zelboraf)
• Nivolumab (Opdivo)
• Nivolumab + Ipilimumab (Opdivo + Yervoy)
• Pembrolizumab (Keytruda)
• Vemurafenib + cobimetinib (Zelboraf + Cotellic)
• Dabrafenib + Trametinib (Tafinlar + Mekinist)
• Braftovi (encorafenib) in combination with Mektovi (binimetinib) for BRAF V600 patients
• Other active systemic anti-cancer therapy [please state]
• Palliative care only
Q2. In the past 3 months (or the latest 3 months data you have available), how many metastatic melanoma patients were treated with the following:
• Ipilimumab
• Ipilimumab AND Nivolumab
• Nivolumab
• Pembrolizumab
• Dabrafenib AND Trametinib
• Any Other Targeted Therapy (Dabrafenib /Encorafenib AND Binimetinib /Trametinib /Vemurafenib /Vemurafenib AND Cobimetinib)
• Other active systemic anti-cancer therapy
• Palliative care only
Thank you for answering these questions.
Yours faithfully,
Ed Fryer
Acknowledgement of your Freedom of Information Act 2000 Request
Thank you for your request for information under the Freedom of
Information Act 2000. This is an acknowledgment of your request. For the
purposes of the Act, your request will be deemed to have been received on
the first working day following delivery. We will reply to your request by
the 20th working day following receipt.
Kind Regards
Information Officer
Freedom of Information
Nottinghamshire Healthcare NHS Foundation Trust
The Resource
Duncan Macmillan House
Porchester Road
Nottingham
NG3 6AA
Direct Dial: 0115 9934521
Please send all emails relating to Freedom of Information to:
[1][email address]
***
This email has been sent from a DCB 1596 Secure Email Certified address.
Confirmation of certification can be found on the NHS Digital Secure Email
Standard web site.
This email and any files transmitted with it are confidential and intended
solely for the use of the individual(s) or entity to whom they are
addressed. If you have received this email in error please notify us
([2][email address]). Any views or opinions presented are
solely those of the sender and do not necessarily represent those of
Nottinghamshire Healthcare NHS Foundation Trust, unless otherwise
specifically stated.
References
Visible links
1. mailto:[email address]
2. mailto:[email address]
Dear Mr Fryer,
Thank you for your Freedom of Information Act request below. We can confirm that your request is not applicable to Nottinghamshire Healthcare NHS Foundation Trust as we do not provide Cancer or Melanoma Services. We provide integrated healthcare services including mental health, intellectual disability and community health services. We also provide secure mental health services and healthcare in prisons across the East Midlands.
Kind Regards
Jo Hill
Freedom of Information Officer
Nottinghamshire Healthcare NHS Foundation Trust
Trust HQ, The Resource,Duncan Macmillan House, Porchester Road, Nottingham. NG3 6AA
Extension: 10221
Direct Dial: 0115 9934521
Please send all emails relating to Freedom of Information to: [email address]
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now